Gilead Sciences, Inc. GILD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

78/100

6/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Gilead Sciences, Inc. (GILD), dont 6 achats et 43 ventes. Le total des achats d'initiés s'élève à $1.48M et le total des ventes d'initiés à $47.6M.

Les initiés notables ayant une activité récente comprennent O'day Daniel Patrick, Dickinson Andrew D, Mercier Johanna. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — GILD

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-27	O'day Daniel Patrick	Chairman & CEO	Vente Informative	10,000	$136.82	$1.37M	642,567
2026-03-16	Dickinson Andrew D	Chief Financial Officer	Vente Informative	3,000	$144.23	$432.69K	179,191
2026-03-16	Mercier Johanna	Chief Comm & Corp Aff Officer	Vente Informative	3,000	$144.23	$432.69K	131,779
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Exercice d'Options (Vente)	6,469	-	-	21,057
2026-03-10	O'day Daniel Patrick	Chairman & CEO	Exercice d'Options (Vente)	20,026	-	-	68,044
2026-03-10	Berger Dietmar	Chief Medical Officer	Retenue Fiscale RSU	1,063	$148.56	$157.92K	18,982
2026-03-10	Mercier Johanna	Chief Comm & Corp Aff Officer	Exercice d'Options (Vente)	6,617	-	-	21,057
2026-03-10	Burkhart Erin	SVP, Controllership	Attribution de RSU	5,455	$148.56	$810.39K	5,455
2026-03-10	Cain Wettan Keeley M	EVP Gen Counsel, Legal & Comp	Retenue Fiscale RSU	606	$148.56	$90.03K	5,054
2026-02-27	Dickinson Andrew D	Chief Financial Officer	Attribution de RSU	11,090	-	-	178,869
2026-02-27	O'day Daniel Patrick	Chairman & CEO	Vente Informative	100	$145.71	$14.57K	642,308
2026-02-27	Berger Dietmar	Chief Medical Officer	Attribution de RSU	8,530	-	-	17,912
2026-02-27	Mercier Johanna	Chief Comm & Corp Aff Officer	Attribution de RSU	11,090	-	-	131,378
2026-02-27	Cain Wettan Keeley M	EVP Gen Counsel, Legal & Comp	Attribution de RSU	470	-	-	4,414
2026-02-17	Dickinson Andrew D	Chief Financial Officer	Vente Informative	3,000	$154.43	$463.29K	167,779
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Exercice d'Options (Vente)	25,000	$66.64	$1.67M	48,110
2026-02-05	O'day Daniel Patrick	Chairman & CEO	Exercice d'Options (Vente)	115,640	$66.01	$7.63M	-
2026-02-04	Cain Wettan Keeley M	EVP Gen Counsel, Legal & Comp	Inconnu	11,342	-	-	-
2026-02-03	Dickinson Andrew D	Chief Financial Officer	Retenue Fiscale RSU	24,802	$143.28	$3.55M	170,568
2026-02-03	O'day Daniel Patrick	Chairman & CEO	Retenue Fiscale RSU	74,461	$143.28	$10.67M	613,912
2026-02-03	Mercier Johanna	Chief Comm & Corp Aff Officer	Retenue Fiscale RSU	24,800	$143.28	$3.55M	123,288
2026-01-28	O'day Daniel Patrick	Chairman & CEO	Vente Informative	4,968	$140.24	$696.73K	556,698
2026-01-23	O'day Daniel Patrick	Chairman & CEO	Exercice d'Options (Vente)	115,640	$66.01	$7.63M	115,640
2026-01-20	Bluestone Jeffrey	Director	Exercice d'Options (Vente)	5,000	$67.45	$337.25K	4,665
2026-01-15	Dickinson Andrew D	Chief Financial Officer	Vente Informative	3,000	$124.31	$372.93K	150,503
2026-01-15	Mercier Johanna	Chief Commercial Officer	Vente Informative	3,000	$124.31	$372.93K	103,221
2026-01-02	Berger Dietmar	Chief Medical Officer	Retenue Fiscale RSU	6,944	$121.60	$844.39K	9,382
2025-12-29	O'day Daniel Patrick	Chairman & CEO	Vente Informative	10,000	$124.83	$1.25M	566,698
2025-12-15	Dickinson Andrew D	Chief Financial Officer	Vente Informative	3,000	$122.00	$366K	153,503
2025-12-15	Mercier Johanna	Chief Commercial Officer	Vente Informative	3,000	$122.00	$366K	106,221
2025-12-10	Dickinson Andrew D	Chief Financial Officer	Exercice d'Options (Vente)	3,693	-	-	27,526
2025-12-10	O'day Daniel Patrick	Chairman & CEO	Exercice d'Options (Vente)	10,426	-	-	88,070
2025-12-10	Mercier Johanna	Chief Commercial Officer	Exercice d'Options (Vente)	3,842	-	-	27,674
2025-11-28	Kramer Kelly A.	Director	Exercice d'Options (Vente)	2,805	$81.00	$227.21K	-
2025-11-28	O'day Daniel Patrick	Chairman & CEO	Vente Informative	6,788	$126.84	$861.02K	571,203
2025-11-28	Bluestone Jeffrey	Director	Exercice d'Options (Vente)	5,000	$64.92	$324.6K	7,648
2025-11-26	Kramer Kelly A.	Director	Vente Informative	2,806	$127.11	$356.67K	1,339
2025-11-17	Dickinson Andrew D	Chief Financial Officer	Vente Informative	2,500	$125.23	$313.08K	154,555
2025-11-17	Mercier Johanna	Chief Commercial Officer	Exercice d'Options (Vente)	25,000	$66.64	$1.67M	73,110
2025-06-16	Dickinson Andrew D	Chief Financial Officer	Vente Informative	2,500	$110.17	$275.43K	165,110
2025-06-16	Mercier Johanna	Chief Commercial Officer	Vente Informative	3,000	$110.17	$330.51K	120,168
2025-06-10	Dickinson Andrew D	Chief Financial Officer	Exercice d'Options (Vente)	3,694	-	-	34,915
2025-06-10	Wilfong Diane E.	Interim Corp Controller & CAO	Exercice d'Options (Vente)	920	-	-	8,785
2025-06-10	O'day Daniel Patrick	Chairman & CEO	Exercice d'Options (Vente)	10,425	-	-	108,923
2025-06-10	Mercier Johanna	Chief Commercial Officer	Exercice d'Options (Vente)	3,843	-	-	35,360
2025-06-10	Telman Deborah H	EVP, Corporate Affairs & Gc	Exercice d'Options (Vente)	1,313	-	-	30,389
2025-05-30	O'day Daniel Patrick	Chairman & CEO	Vente Informative	3,584	$110.96	$397.69K	620,268
2025-05-22	Mercier Johanna	Chief Commercial Officer	Vente Informative	3,000	$107.52	$322.56K	121,152
2025-05-15	Dickinson Andrew D	Chief Financial Officer	Vente Informative	2,500	$99.82	$249.55K	165,674
2025-05-07	Barton Jacqueline K	Director	Attribution de RSU	6,809	$98.90	$673.41K	6,809

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration